Skip to main content Back to Top
Advertisement

11/25/2019

Nitrofurantoin Oral Suspension

Products Affected - Description

    • Furadantin oral suspension, Casper, 25 mg/5 mL, 230 mL bottle, NDC 70199-0006-32
    • Nitrofurantoin oral suspension, Amneal, 25 mg/5 mL, 230 mL bottle, UPC 65162-0689-88
    • Nitrofurantoin oral suspension, Lupin, 25 mg/5 mL, 230 mL bottle, UPC 43386-0450-11 - discontinued
    • Nitrofurantoin oral suspension, Teva, 25 mg/5 mL, 230 mL bottle, UPC 00472-1992-08

Reason for the Shortage

    • Amneal stated the shortage of nitrofurantoin oral suspension is due to manufacturing delays.
    • Casper Pharma stated the Furadantin shortage is due to manufacturing delays.
    • Lupin is no longer manufacturing this product.
    • Nostrum has nitrofurantoin oral suspension available.
    • Teva did not provide a reason for the shortage.

Available Products

    • Nitrofurantoin oral suspension, Nostrum, 25 mg/5 mL, 240 mL bottle, UPC 70408-0239-32

Estimated Resupply Dates

    • Amneal has nitrofurantoin oral suspension temporarily unavailable and the company cannot estimate a release date.
    • Casper has Furadantin oral suspension on back order and the company cannot estimate a release date.
    • Teva has nitrofurantoin oral suspension temporarily unavailable and the company cannot estimate a release date.

Alternative Agents & Management

    • Nitrofurantoin 2 mg/mL suspension can be made from nitrofurantoin bulk powder and SyrSpend SF PH4 vehicle. Mix nitrofurantoin with a small amount of suspending vehicle to form a paste. Dilute the paste with additional SyrSpendSF to a final volume of 300 mL. Store at room temperature or under refrigeration in light-resistant bottles. Suspension is stable for 90 days.[1]
    • Macrodantin (nitrofurantoin macrocrystalline) capsules can be opened and mixed with food or water and flushed down a tube.[2]
    • Macrobid (nitrofurantoin monohydrate/macrocrystalline) capsules should not be opened as this may interfere with the nitrofurantoin release mechanism.[2]

References

    1. De Oliveira, FA, Polonini HC, Loures da Silva S, et al., (2017). Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantion, Ondansetron HCl, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF PH4 Oral Suspensions. International Journal of Pharmaceutical Compounding, 21(3), 255-263.
    2. Alvogen Customer Service (personal communications). June 5, 2018.

Updated

Updated November 25, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 5, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins